ZVRA
insider transactionsZEVRA THERAPEUTICS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 3 different insiders made open-market purchases in the last 365 days, totalling $228.4K.
Net shares · 365d
-150.0K
28.2K buy · 178.2K sell
Net value · 365d
-$1.4M
$228.4K in · $1.7M out
Sentiment · 365d
Net selling
12% buying · 88% selling
Open-market trades · 365d
14
28.2K buy · 178.2K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 365d
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
SVP, Finance & Corp Controller
$0
60.0K sh · 2 lots
Own New
-
Sell·S
Chief Legal & Compliance · 10b5-1
$20.3K
1.8K sh · $11.30
Own -4%
-
Exercise·M
Director
$0
78.4K sh · 2 lots
Own New
-
Exercise·M
Director
$386.5K
78.4K sh · $4.93 avg · 2 lots
Own +174%
-
Grant·A
Renz Justin A KEY
CFO
$0
300.0K sh
Own New
-
Sell·S
President and CEO · 10b5-1
$125.2K
14.6K sh · $8.56
Own -4%
-
Exercise·M
President and CEO · 10b5-1
$0
37.5K sh
Own +100%
-
Exercise·M
President and CEO · 10b5-1
—
37.5K sh
Own +10%
-
Sell·S
SVP, Finance & Corp Controller · 10b5-1
$27.5K
3.0K sh · $9.18
Own -9%
-
Sell·S
CCO · 10b5-1
$96.5K
10.5K sh · $9.19
Own -14%
-
Sell·S
President and CEO · 10b5-1
$853.6K
91.0K sh · $9.38
Own -20%
-
Exercise·M
CCO · 10b5-1
$0
46.7K sh · 2 lots
Own New
-
Exercise·M
CCO · 10b5-1
—
46.7K sh · 2 lots
Own +179%
-
Exercise·M
President and CEO · 10b5-1
$0
233.3K sh
Own New
-
Exercise·M
President and CEO · 10b5-1
—
233.3K sh
Own +105%
-
Exercise·M
SVP, Finance & Corp Controller · 10b5-1
$0
18.0K sh · 2 lots
Own New
-
Exercise·M
SVP, Finance & Corp Controller · 10b5-1
—
18.0K sh · 2 lots
Own +123%
-
Sell·S
CCO · 10b5-1
$29.8K
3.4K sh · $8.83
Own -8%
-
Exercise·M
Chief Legal & Compliance · 10b5-1
$0
11.3K sh
Own +100%
-
Exercise·M
Chief Legal & Compliance · 10b5-1
—
11.3K sh
Own +27%
-
Sell·S
Chief Legal & Compliance · 10b5-1
$36.0K
4.1K sh · $8.83
Own -8%
-
Sell·S
SVP, Finance & Corp Controller · 10b5-1
$15.4K
1.8K sh · $8.82
Own -8%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
11.3K sh
Own +100%
-
Exercise·M
Chief Medical Officer · 10b5-1
—
11.3K sh
Own +388%
-
Sell·S
Chief Medical Officer · 10b5-1
$40.0K
4.5K sh · $8.83
Own -32%
-
Grant·A
CCO · 10b5-1
$0
112.5K sh · 2 lots
Own New
-
Grant·A
Chief Legal & Compliance · 10b5-1
$0
112.5K sh · 2 lots
Own New
-
Grant·A
President and CEO · 10b5-1
$0
375.0K sh · 2 lots
Own New
-
Grant·A
Chief Medical Officer · 10b5-1
$0
112.5K sh · 2 lots
Own New
-
Exercise·M
Other
$0
140.7K sh · 3 lots
Own New
-
Exercise·M
Other
$0
140.7K sh
Own +274%
-
Other·F
Other
$434.7K
48.5K sh · $8.96
Own -25%
-
Grant·A
Director
$0
45.0K sh
Own New
-
Exercise·M
President and CEO · 10b5-1
$0
50.0K sh
Own +100%
-
Sell·S
President and CEO · 10b5-1
$211.0K
19.5K sh · $10.82
Own -8%
-
Exercise·M
President and CEO · 10b5-1
—
50.0K sh
Own +26%
-
Buy·P
Director
$157.8K
20.0K sh · $7.89
Own New
-
Buy·P
Director
$24.7K
3.2K sh · $7.79
Own +442%
-
Buy·P
Director
$45.9K
5.0K sh · $9.17
Own +12%
-
Sell·S
Chief Legal & Compliance · 10b5-1
$221.0K
24.0K sh · $9.21
Own -36%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | Watton Corey Michael | Grant A | 30.0K | $0 |
| Jun 4, 2026 | Shih Alvin | Grant A | 30.0K | $0 |
| Jun 4, 2026 | Secor Alicia | Grant A | 30.0K | $0 |
| Jun 4, 2026 | SEYMOUR TAMARA A | Grant A | 30.0K | $0 |
| Jun 4, 2026 | Calder Douglas W | Grant A | 30.0K | $0 |
| Jun 4, 2026 | Anderson Thomas | Grant A | 30.0K | $0 |
| May 28, 2026 | Sangiovanni Timothy J. | Grant A | 60.0K2 lots | $0 |
| May 11, 2026 | Thompson Rahsaan 10b5-1 | Sell S | 1.8K | $20.3K |
| Mar 24, 2026 | Bode John B | Exercise M | 78.4K2 lots | $0 |
| Mar 24, 2026 | Bode John B | Exercise M | 78.4K2 lots | $386.5K |
| Mar 18, 2026 | Renz Justin A KEY | Grant A | 300.0K | $0 |
| Feb 9, 2026 | McFarlane Neil F. KEY 10b5-1 | Sell S | 14.6K | $125.2K |
| Feb 7, 2026 | McFarlane Neil F. KEY 10b5-1 | Exercise M | 37.5K | $0 |
| Feb 7, 2026 | McFarlane Neil F. KEY 10b5-1 | Exercise M | 37.5K | — |
| Feb 3, 2026 | Sangiovanni Timothy J. 10b5-1 | Sell S | 3.0K | $27.5K |
| Feb 3, 2026 | Schafer Joshua 10b5-1 | Sell S | 10.5K | $96.5K |
| Feb 2, 2026 | McFarlane Neil F. KEY 10b5-1 | Sell S | 91.0K | $853.6K |
| Jan 31, 2026 | Schafer Joshua 10b5-1 | Exercise M | 46.7K2 lots | $0 |
| Jan 31, 2026 | Schafer Joshua 10b5-1 | Exercise M | 46.7K2 lots | — |
| Jan 31, 2026 | McFarlane Neil F. KEY 10b5-1 | Exercise M | 233.3K | $0 |
| Jan 31, 2026 | McFarlane Neil F. KEY 10b5-1 | Exercise M | 233.3K | — |
| Jan 31, 2026 | Sangiovanni Timothy J. 10b5-1 | Exercise M | 18.0K2 lots | $0 |
| Jan 31, 2026 | Sangiovanni Timothy J. 10b5-1 | Exercise M | 18.0K2 lots | — |
| Jan 30, 2026 | Schafer Joshua 10b5-1 | Sell S | 3.4K | $29.8K |
| Jan 30, 2026 | Thompson Rahsaan 10b5-1 | Exercise M | 11.3K | $0 |
| Jan 30, 2026 | Thompson Rahsaan 10b5-1 | Exercise M | 11.3K | — |
| Jan 30, 2026 | Thompson Rahsaan 10b5-1 | Sell S | 4.1K | $36.0K |
| Jan 30, 2026 | Sangiovanni Timothy J. 10b5-1 | Sell S | 1.8K | $15.4K |
| Jan 30, 2026 | Quartel Adrian W 10b5-1 | Exercise M | 11.3K | $0 |
| Jan 30, 2026 | Quartel Adrian W 10b5-1 | Exercise M | 11.3K | — |
| Jan 30, 2026 | Quartel Adrian W 10b5-1 | Sell S | 4.5K | $40.0K |
| Jan 29, 2026 | Schafer Joshua 10b5-1 | Grant A | 112.5K2 lots | $0 |
| Jan 29, 2026 | Thompson Rahsaan 10b5-1 | Grant A | 112.5K2 lots | $0 |
| Jan 29, 2026 | McFarlane Neil F. KEY 10b5-1 | Grant A | 375.0K2 lots | $0 |
| Jan 29, 2026 | Quartel Adrian W 10b5-1 | Grant A | 112.5K2 lots | $0 |
| Dec 31, 2025 | Clifton R. LaDuane | Exercise M | 140.7K3 lots | $0 |
| Dec 31, 2025 | Clifton R. LaDuane | Exercise M | 140.7K | $0 |
| Dec 31, 2025 | Clifton R. LaDuane | Other F | 48.5K | $434.7K |
| Dec 2, 2025 | Secor Alicia | Grant A | 45.0K | $0 |
| Oct 10, 2025 | McFarlane Neil F. KEY 10b5-1 | Exercise M | 50.0K | $0 |
| Oct 10, 2025 | McFarlane Neil F. KEY 10b5-1 | Sell S | 19.5K | $211.0K |
| Oct 10, 2025 | McFarlane Neil F. KEY 10b5-1 | Exercise M | 50.0K | — |
| Sep 12, 2025 | Shih Alvin | Buy P | 20.0K | $157.8K |
| Sep 12, 2025 | SEYMOUR TAMARA A | Buy P | 3.2K | $24.7K |
| Aug 19, 2025 | Bode John B | Buy P | 5.0K | $45.9K |
| Jun 26, 2025 | Thompson Rahsaan 10b5-1 | Sell S | 24.0K | $221.0K |
Buy Sell Non-market (grant · exercise · gift)
About ZVRA insider trading
This page tracks insider transactions for ZEVRA THERAPEUTICS, INC. (ZVRA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.